Heart failure with preserved ejection fraction: disease burden for patients, caregivers, and the health-care system

References

• Yancy CW, Jessup M, Bozkurt B, et al. ACCF/AHA guideline for the management of heart failure. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation. 2013;128(16):e240–e327.
   PubMed Web of Science ®Google Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891–975.
   PubMed Web of Science ®Google Scholar
• Virani SS, Alonso A, Benjamin EJ, et al. Heart disease and stroke statistics-2020 update: a report from the American Heart Association. Circulation. 2020;141(9):e139–e596.
   PubMed Web of Science ®Google Scholar
• Hsu JJ, Ziaeian B, Fonarow GC. Heart failure with mid-range (borderline) ejection fraction: clinical implications and future directions. JACC Heart Fail. 2017;5(11):763–771.
   PubMed Web of Science ®Google Scholar
• Basuray A, French B, Ky B, et al. Heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes. Circulation. 2014;129(23):2380–2387.
   PubMed Web of Science ®Google Scholar
• Ho JE, Zern EK, Wooster L, et al. Differential clinical profiles, exercise responses, and outcomes associated with existing HFpEF definitions. Circulation. 2019;140(5):353–365.
   PubMed Web of Science ®Google Scholar
• Senni M, Caravita S, Paulus WJ. Do existing definitions identify subgroup phenotypes or reflect the natural history of heart failure with preserved ejection fraction? Circulation. 2019;140(5):366–369.
   PubMed Web of Science ®Google Scholar
• Rogers FJ, Gundala T, Ramos JE, et al. Heart failure with preserved ejection fraction. J Am Osteopath Assoc. 2015;115(7):432–442.
   PubMed Web of Science ®Google Scholar
• Tan YT, Wenzelburger F, Lee E, et al. The pathophysiology of heart failure with normal ejection fraction: exercise echocardiography reveals complex abnormalities of both systolic and diastolic ventricular function involving torsion, untwist, and longitudinal motion. J Am Coll Cardiol. 2009;54(1):36–46.
   PubMed Web of Science ®Google Scholar
• Reddy YNV, Borlaug BA. Heart failure with preserved ejection fraction. Curr Probl Cardiol. 2016;41(4):145–188.
   PubMed Web of Science ®Google Scholar
• Sharma K, Kass DA. Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies. Circ Res. 2014;115(1):79–96.
   PubMed Web of Science ®Google Scholar
• Paulus WJ, Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol. 2013;62(4):263–271.
   PubMed Web of Science ®Google Scholar
• Pfeffer MA, Shah AM, Borlaug BA. Heart failure with preserved ejection fraction in perspective. Circ Res. 2019;124(11):1598–1617.
   PubMed Web of Science ®Google Scholar
• Borlaug BA. Evaluation and management of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2020;17(9):559–573.
   Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines and the Heart Failure Society of America. Circulation. 2017;136(6):e137–e161.
   PubMed Web of Science ®Google Scholar
• Gazewood JD, Turner PL. Heart failure with preserved ejection fraction: diagnosis and management. Am Fam Physician. 2017;96(9):582–588.
   PubMed Web of Science ®Google Scholar
• Gladden JD, Linke WA, Redfield MM. Heart failure with preserved ejection fraction. Pflugers Arch. 2014;466(6):1037–1053.
   PubMed Web of Science ®Google Scholar
• Mureddu GF, Agabiti N, Rizzello V, et al. Prevalence of preclinical and clinical heart failure in the elderly. A population-based study in Central Italy. Eur J Heart Fail. 2012;14(7):718–729.
   PubMed Web of Science ®Google Scholar
• Oktay AA, Shah SJ. Diagnosis and management of heart failure with preserved ejection fraction: 10 key lessons. Curr Cardiol Rev. 2015;11(1):42–52.
   PubMed Web of Science ®Google Scholar
• Owan TE, Hodge DO, Herges RM, et al. Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med. 2006;355(3):251–259.
   PubMed Web of Science ®Google Scholar
• Huis in ‘t Veld AE, de Man FS, van Rossum AC, et al. How to diagnose heart failure with preserved ejection fraction: the value of invasive stress testing. Neth Heart J. 2016;24(4):244–251.
   PubMed Web of Science ®Google Scholar
• Deaton C, Benson J. Time for correct diagnosis and categorisation of heart failure in primary care. Br J Gen Pract. 2016;66(652):554–555.
   PubMed Web of Science ®Google Scholar
• Packer M. HFpEF is the substrate for stroke in obesity and diabetes independent of atrial fibrillation. JACC Heart Fail. 2020;8(1):35–42.
   PubMed Web of Science ®Google Scholar
• Mesquita ET, Lagoeiro Jorge AJ, Rabelo LM, et al. Understanding hospitalization in patients with heart failure. Int J Cardiovasc Sci. 2017;30(1):81–90.
   Google Scholar
• Klapholz M, Maurer M, Lowe AM, et al. Hospitalization for heart failure in the presence of a normal left ventricular ejection fraction: results of the New York Heart Failure Registry. J Am Coll Cardiol. 2004;43(8):1432–1438.
   PubMed Web of Science ®Google Scholar
• Hollenberg SM, Warner Stevenson L, Ahmad T, et al. 2019 ACC expert consensus decision pathway on risk assessment, management, and clinical trajectory of patients hospitalized with heart failure: A report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2019;74(15):1966–2011.
   PubMed Web of Science ®Google Scholar
• Campbell RT, Jhund PS, Castagno D, et al. What have we learned about patients with heart failure and preserved ejection fraction from DIG-PEF, CHARM-preserved, and I-PRESERVE? J Am Coll Cardiol. 2012;60(23):2349–2356.
   PubMed Web of Science ®Google Scholar
• Bello NA, Claggett B, Desai AS, et al. Influence of previous heart failure hospitalization on cardiovascular events in patients with reduced and preserved ejection fraction. Circ Heart Fail. 2014;7(4):590–595.
   PubMed Web of Science ®Google Scholar
• Cowie MR, Lopatin YM, Saldarriaga C, et al. The Optimize Heart Failure Care Program: initial lessons from global implementation. Int J Cardiol. 2017;236:340–344.
   PubMed Web of Science ®Google Scholar
• Nichols GA, Reynolds K, Kimes TM, et al. Comparison of risk of re-hospitalization, all-cause mortality, and medical care resource utilization in patients with heart failure and preserved versus reduced ejection fraction. Am J Cardiol. 2015;116(7):1088–1092.
   PubMed Web of Science ®Google Scholar
• Vaduganathan M, Claggett BL, Desai AS, et al. Prior heart failure hospitalization, clinical outcomes, and response to sacubitril/valsartan compared with valsartan in HFpEF. J Am Coll Cardiol. 2020;75(3):245–254.
   PubMed Web of Science ®Google Scholar
• Perez de Isla L, Cañadas V, Contreras L, et al. Diastolic heart failure in the elderly: in-hospital and long-term outcome after the first episode. Int J Cardiol. 2009;134(2):265–270.
   PubMed Web of Science ®Google Scholar
• Shah KS, Xu H, Matsouaka RA, et al. Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes. J Am Coll Cardiol. 2017;70(20):2476–2486.
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Roger VL, Redfield MM. Epidemiology of heart failure with preserved ejection fraction. Nat Rev Cardiol. 2017;14(10):591–602.
   PubMed Web of Science ®Google Scholar
• Lam CSP, Gamble GD, Ling LH, et al. Mortality associated with heart failure with preserved vs. reduced ejection fraction in a prospective international multi-ethnic cohort study. Eur Heart J. 2018;39(20):1770–1780.
   PubMed Web of Science ®Google Scholar
• Zile MR, Gaasch WH, Anand IS, et al. Mode of death in patients with heart failure and a preserved ejection fraction. Results from the Irbesartan in Heart Failure With Preserved Ejection Fraction Study (I-preserve) trial. Circulation. 2010;121(12):1393–1405.
   PubMed Web of Science ®Google Scholar
• Ergatoudes C, Schaufelberger M, Andersson B, et al. Non-cardiac comorbidities and mortality in patients with heart failure with reduced vs. preserved ejection fraction: a study using the Swedish Heart Failure Registry. Clin Res Cardiol. 2019;108(9):1025–1033.
   PubMed Web of Science ®Google Scholar
• Ather S, Chan W, Bozkurt B, et al. Impact of noncardiac comorbidities on morbidity and mortality in a predominantly male population with heart failure and preserved versus reduced ejection fraction. J Am Coll Cardiol. 2012;59(11):998–1005.
   PubMed Web of Science ®Google Scholar
• Upadhya B, Pisani B, Kitzman DW. Evolution of a geriatric syndrome: pathophysiology and treatment of heart failure with preserved ejection fraction. J Am Geriatr Soc. 2017;65(11):2431–2440.
   PubMed Web of Science ®Google Scholar
• Schichtel M, Wee B, Perera R, et al. The effect of advance care planning on heart failure: a systematic review and meta-analysis. J Gen Intern Med. 2020;35(3):874–884.
   PubMed Web of Science ®Google Scholar
• Nishikawa Y, Hiroyama N, Fukahori H, et al. Advance care planning for adults with heart failure. Cochrane Database Syst Rev. 2020;2(2):CD013022.
   PubMedGoogle Scholar
• Chandra A, Vaduganathan M, Lewis EF, et al. Health-related quality of life in heart failure with preserved ejection fraction: the PARAGON-HF trial. JACC Heart Fail. 2019;7(10):862–874.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Rizkala AR, Lefkowitz MP, et al. Baseline characteristics of patients with heart failure and preserved ejection fraction in the PARAGON-HF trial. Circ Heart Fail. 2018;11(7):e004962.
   PubMed Web of Science ®Google Scholar
• Solomon SD, Rizkala AR, Gong J, et al. Angiotensin receptor neprilysin inhibition in heart failure with preserved ejection fraction: rationale and design of the PARAGON-HF trial. JACC Heart Fail. 2017;5(7):471–482.
   PubMed Web of Science ®Google Scholar
• Warraich HJ, Kitzman DW, Whellan DJ, et al. Physical function, frailty, cognition, depression, and quality of life in hospitalized adults ≥60 years with acute decompensated heart failure with preserved versus reduced ejection fraction. Circ Heart Fail. 2018;11(11):e005254.
   PubMed Web of Science ®Google Scholar
• Shah SJ, Heitner JF, Sweitzer NK, et al. Baseline characteristics of patients in the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial. Circ Heart Fail. 2013;6(2):184–192.
   PubMed Web of Science ®Google Scholar
• Reeves GR, Whellan DJ, Patel MJ, et al. Comparison of frequency of frailty and severely impaired physical function in patients ≥60 years hospitalized with acute decompensated heart failure versus chronic stable heart failure with reduced and preserved left ventricular ejection fraction. Am J Cardiol. 2016;117(12):1953–1958.
   PubMed Web of Science ®Google Scholar
• Molloy GJ, Johnston DW, Witham MD. Family caregiving and congestive heart failure. Review and analysis. Eur J Heart Fail. 2005;7(4):592–603.
   PubMed Web of Science ®Google Scholar
• Pressler SJ, Gradus-Pizlo I, Chubinski SD, et al. Family caregiver outcomes in heart failure. Am J Crit Care. 2009;18(2):149–159.
   PubMed Web of Science ®Google Scholar
• Jackson JDS, Cotton SE, Bruce Wirta S, et al. Burden of heart failure on caregivers in China: results from a cross-sectional survey. Drug Des Devel Ther. 2018;12:1669–1678.
   PubMed Web of Science ®Google Scholar
• Lang CC, Smith K, Wingham J, et al. A randomised controlled trial of a facilitated home-based rehabilitation intervention in patients with heart failure with preserved ejection fraction and their caregivers: the REACH-HFpEF pilot study. BMJ Open. 2018;8(4):e019649.
   PubMed Web of Science ®Google Scholar
• Joo H, Fang J, Losby JL, et al. Cost of informal caregiving for patients with heart failure. Am Heart J. 2015;169(1):142–148.e2.
   PubMed Web of Science ®Google Scholar
• Dirikkan F, Baysan Arabaci L, Mutlu E. The caregiver burden and the psychosocial adjustment of caregivers of cardiac failure patients. Turk Kardiyol Dern Ars. 2018;46(8):692–701.
   PubMed Web of Science ®Google Scholar
• Fitzsimons D, Doherty LC, Murphy M, et al. Inadequate communication exacerbates the support needs of current and bereaved caregivers in advanced heart failure and impedes shared decision-making. J Cardiovasc Nurs. 2019;34(1):11–19.
   PubMed Web of Science ®Google Scholar
• Sobral Lacerda M, Rezende do Prado P, Bottura Leite de Barros AL, et al. Depressive symptoms in the family caregivers of patients with heart failure: an integrative review. Rev Gaucha Enferm. 2019;40:e20180057.
   PubMedGoogle Scholar
• McIlfatrick S, Doherty LC, Murphy M, et al. ‘The importance of planning for the future’: burden and unmet needs of caregivers’ in advanced heart failure: A mixed methods study. Palliat Med. 2018;32(4):881–890.
   PubMed Web of Science ®Google Scholar
• Nicholas Dionne-Odom J, Hooker SA, Bekelman D, et al. Family caregiving for persons with heart failure at the intersection of heart failure and palliative care: a state-of-the-science review. Heart Fail Rev. 2017;22(5):543–557.
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Roger VL, Weston SA, et al. Patient and spousal health and outcomes in heart failure. Circ Heart Fail. 2017;10(10):e004088.
   PubMed Web of Science ®Google Scholar
• Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States. A policy statement from the American Heart Association. Circ Heart Fail. 2013;6(3):606–619.
   PubMed Web of Science ®Google Scholar
• Murphy TM, Waterhouse DF, James S, et al. A comparison of HFrEF vs HFpEF’s clinical workload and cost in the first year following hospitalization and enrollment in a disease management program. Int J Cardiol. 2017;232:330–335.
   PubMed Web of Science ®Google Scholar
• Oktay AA, Rich JD, Shah SJ. The emerging epidemic of heart failure with preserved ejection fraction. Curr Heart Fail Rep. 2013;10(4):401–410.
   PubMedGoogle Scholar
• Deaton C, Edwards D, Malyon A, et al. The tip of the iceberg: finding patients with heart failure with preserved ejection fraction in primary care. An observational study. BJGP Open. 2018;2(3):bjgpopen18X101606.
   PubMedGoogle Scholar